[Diagnostic image; a man with severe radiation dermatitis].
A 51-year-old man with concurrent radiotherapy and cetuximab for tongue cancer developed a moist desquamation, spontaneous bleeding and necrosis of the skin after 42 Gy. The skin healed after cetuximab was discontinued.
Janssens
Geert O R J
GO
Universitair Medisch Centrum St Radboud, Afd. Radiotherapie, Nijmegen, The Netherlands. g.janssens@rther.umcn.nl
van Herpen
Carla M L
CM
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068818:Cetuximab; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011855:Radiodermatitis / Q000209:etiology*; D011878:Radiotherapy / Q000009:adverse effects; D014062:Tongue Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab